# CISATRACURIUM BESYLATE
> **ANDA216538** · Abbreviated New Drug Application (Generic) · Sponsor: HAINAN POLY · Approved 2024-03-08
## Drug
- **FDA Application Number:** ANDA216538
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CISATRACURIUM BESYLATE
- **Generic name:** CISATRACURIUM BESYLATE
- **Active ingredients:** CISATRACURIUM BESYLATE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Discontinued
- **Sponsor:** HAINAN POLY
- **Manufacturer:** Slate Run Pharmaceuticals, LLC
- **First approval:** 2024-03-08
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216538)
---
*AI Analytics · CC0 1.0*